- Poseida Therapeutics Inc P-BCMA-ALLO1 Clinical Data Call TranscriptDec 10, 2023
- Poseida Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Poseida Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Poseida Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Poseida Therapeutics Inc at HC Wainwright Cell Therapy Virtual Conference TranscriptFeb 28, 2023
- Poseida Therapeutics Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Poseida Therapeutics Inc at Stifel Healthcare Conference TranscriptNov 16, 2022
- Poseida Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Poseida Therapeutics Inc Collaboration and Poseida's Novel Approach to Allogeneic Cell Therapy - Corporate Call TranscriptAug 03, 2022
- Poseida Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
Poseida Therapeutics Inc Collaboration and Poseida's Novel Approach to Allogeneic Cell Therapy - Corporate Call Transcript
Welcome to Poseida Therapeutics' investor call. Thank you for joining us for today's presentation. My name is Gretchen, and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being recorded and that there will be no Q&A following this presentation.
Presenting today is Poseida's CEO, Mark Gergen. Earlier this morning, Poseida issued a press release announcing its strategic global collaboration with Roche, focused on utilizing Poseida's proprietary platform technologies to develop allogeneic CAR-T-cell therapy for hematologic malignancies. Poseida encourages everyone to read today's press release and the associated materials which have been filed with the SEC. Additionally, the press release presentation and recording on this website can be found under the Investors section of the company's website at www.poseida.com
Please note that certain information discussed on today's call contains forward-looking statements within the meaning of the Private Securities Litigation
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)